TY - JOUR
KW - Drug Abuse And Alcoholism
KW - Screening
KW - Qualitative Research
KW - Substance abuse disorders
KW - Accountability
KW - Clinical decision making
KW - Telemedicine
KW - Interviews
KW - Semistructured interviews
KW - Visits
KW - COVID-19
KW - Pandemics
KW - Personal safety
KW - Opioids
KW - buprenorphine
KW - Quality of Care
KW - Coronaviruses
KW - Toxicology
KW - narcotics
KW - Substance abuse treatment
AU - Lori Uscher-Pines
AU - Jessica Sousa
AU - Pushpa Raja
AU - Ateev Mehrotra
AU - Michael Barnett
AU - Haiden A. Huskamp
A1 - 
AD - RAND Corporation, Arlington, VA, United States of America ; RAND Corporation, Boston, MA, United States of America ; Greater Los Angeles VA Medical Center, Los Angeles, CA, United States of America ; Department of Health Care Policy, Harvard Medical School, Boston, MA, United States of America ; Harvard T H Chan School of Public Health Boston, MA, United States of America ; RAND Corporation, Arlington, VA, United States of America
BT - Journal of substance abuse treatment
C5 - Education & Workforce; HIT & Telehealth; Opioids & Substance Use
CY - Elmsford
DO - 10.1016/j.jsat.2020.108124
JF - Journal of substance abuse treatment
LA - English
M1 - Journal Article
PB - Elsevier Limited
PP - Elmsford
PY - 2020
SN - 07405472
SP - 1
T1 - Treatment of opioid use disorder during COVID-19: Experiences of clinicians transitioning to telemedicine
T2 - Journal of substance abuse treatment
TI - Treatment of opioid use disorder during COVID-19: Experiences of clinicians transitioning to telemedicine
U1 - Education & Workforce; HIT & Telehealth; Opioids & Substance Use
U3 - 10.1016/j.jsat.2020.108124
VL - 118
VO - 07405472
Y1 - 2020
Y2 - 11
ER -